Plasma pyridoxal 5′-phosphate in the US population:: the National Health and Nutrition Examination Survey, 2003-2004
Plasma pyridoxal 5′-phosphate in the US population:: the National Health and Nutrition Examination Survey, 2003-2004
复制标题
DOI:
10.1093/ajcn/87.5.1446
复制
发表时间:
2008-05-01
影响因子:
7.1
通讯作者:
Selhub, Jacob
中科院分区:
文献类型:
--
作者:
Morris, Martha Savaria;Picciano, Mar Frances;Selhub, Jacob
Background: No large-scale, population-based study has considered the descriptive epidemiology of vitamin B-6 status with use of plasma pyridoxal 5'-phosphate (PLP), the indicator of vitamin B-6 adequacy used to set the current Recommended Dietary Allowance, which is 6000 participants aged >= 1 y in the National Health and Nutrition Examination Survey (2003-2004), we considered relations between plasma PLP and various subject characteristics and examined trends in plasma PLP and homocysteine with vitamin B-6 intake, both overall and in selected subgroups.Results: In males, plasma PLP decreased with age after adolescence only in nonusers of supplemental vitamin B-6. Regardless of supplement use, plasma PLP concentrations of women of childbearing age were significantly lower than those of comparably aged men, and most oral contraceptive users had plasma PLP 3% at vitamin B-6 intakes from 2 to 2.9 mg/d in all subgroups and at intakes from 3 to 4.9 mg/d in smokers, the elderly, non-Hispanic blacks, and current and former oral contraceptive users. Intakes from 3 to 4.9 mg/d compared with